Whitehawk Therapeutics, Inc. — Director's Dealing 2018

Nov 16, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aerpio Pharmaceuticals, Inc. (ARPO)
CIK: 0001422142
Period of Report: 2018-10-26

Reporting Person: Dugel Pravin (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-10-26	Stock Option (Right to Buy)	$2.05	A	2500	Acquired	2028-10-26	Common Stock (2500)	Direct

Footnotes

F1: Options fully vest on the date of grant, subject to the director's service on the Board at such time.